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Collagen fibrillogenesis: fibronectin, integrins, and minor
collagens as organizers and nucleators
Karl E Kadler, Adele Hill and Elizabeth G Canty-LairdCollagens are triple helical proteins that occur in the
extracellular matrix (ECM) and at the cell–ECM interface. There
are more than 30 collagens and collagen-related proteins but
the most abundant are collagens I and II that exist asD-periodic
(where D = 67 nm) fibrils. The fibrils are of broad biomedical
importance and have central roles in embryogenesis, arthritis,
tissue repair, fibrosis, tumor invasion, and cardiovascular
disease. Collagens I and II spontaneously form fibrils in vitro,
which shows that collagen fibrillogenesis is a selfassembly
process. However, the situation in vivo is not that simple;
collagen I-containing fibrils do not form in the absence of
fibronectin, fibronectin-binding and collagen-binding integrins,
and collagen V. Likewise, the thin collagen II-containing fibrils in
cartilage do not form in the absence of collagen XI. Thus, in
vivo, cellular mechanisms are in place to control what is
otherwise a protein self-assembly process. This review puts
forward a working hypothesis for how fibronectin and integrins
(the organizers) determine the site of fibril assembly, and
collagens V and XI (the nucleators) initiate collagen
fibrillogenesis.
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Introduction
A crucial event in limb development occurs soon after
mesenchymal condensation when collagen fibrils begin
to appear in the extracellular matrix (ECM) of rudi-
mentary tendons, ligaments, bones, and joints. The
fibrils increase in size and abundance during embryonic
and postnatal development until they become the most
abundant structural element in adult tissues. Our
understanding of how collagen fibrillogenesis is
initiated and regulated is limited, and this represents
a major setback to attempts in regenerative medicine to
Open access under CC BY license.www.sciencedirect.comreplace ECM-rich organs and tissues lost to disease or
trauma.
The collagen fibril enigma
Collagen I fibril formation in vitro is a straightforward
example of entropy-driven protein self-assembly/
polymerization and has a critical concentration of
1 nM at 37 8C (see [1] and references therein). Early
experiments showed that collagen I could be extracted
from tissues in dilute acidic solutions or high-salt buffers
and reconstituted into fibrils by neutralizing and/or warm-
ing the solutions [2]. Subsequent studies identified bind-
ing sites on the collagen monomers for fibril formation [3].
The case for support for collagen self-polymerization is
strengthened by the fact that collagen is synthesized as a
soluble precursor, procollagen, containingN-terminal and
C-terminal propeptides. The propeptides are cleavable
by procollagen N-proteinases and C-proteinases (for
review see [4] and references therein). Moreover, clea-
vage of the C-propeptides by the BMP-1/tolloid family of
metalloproteinases is sufficient to initiate collagen fibril-
logenesis in vitro [5]. These studies provide unequivocal
proof that collagen fibril formation can occur readily in the
absence of cells. Consequently, the absolute requirement
for noncollagenous molecules to initiate collagen fibrillo-
genesis in vivo is mystifying.
The answer to this riddle most probably lies in the fact
that fibrillar collagens have 50 known binding partners
in vivo [6]. This number of binding partners is presumably
required to generate the diversity of fibril patterns, which
range from parallel bundles in tendon and ligament, to
orthogonal lattices in cornea, and interlocking weaves in
blood vessels, skin, and bone. On the contrary, having a
large number of binding partners can spell disaster for a
protein self-assembly/polymerization process. Purified
collagen spontaneously assembles into fibrils in vitro
because collagen molecules are free to bind to other
collagen molecules, and only collagen molecules. In vivo,
however, the situation is very different. Faced with so
many potential-binding partners, collagen molecules
might easily be sequestered into dead-end molecular
interactions, which would lower the effective concen-
tration of collagen monomers available to form fibrils.
In the remainder of the review, we explore the possibility
that cells use collagen V and XI to nucleate collagen
fibrils, and fibronectin (FN) and integrins to specify their
site of assembly. By localizingfibril formation to theplasma
membrane the cell maintains tight regulatory control of
collagen fibrillogenesis, which is clearly essential for theCurrent Opinion in Cell Biology 2008, 20:495–501
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fibrils in different tissues.
The organizers — fibronectin and integrins
Several molecules are involved in the biosynthesis of
collagen. These include ER-resident glycosyltransferases
and isomerases as well as the collagen-specific molecular
chaperone Hsp47. Furthermore, the ADAMTS procolla-
gen N-proteinases and BMP-1/tolloid C-proteinases are
essential for the conversion of procollagen to a fibrillo-
genesis-competent molecule. However, leaving aside
these important biosynthetic proteins, FN and integrins
appear to be essential for the formation of collagen fibrils
by cultured cells (see below) and mesenchymal embryo-
nic cells in vivo (Hill and Kadler, in preparation). The
detailed mechanism of FN-mediated and integrin-
mediated collagen fibrillogenesis has not been elucidated.
FN is secreted as a disulfide-bonded dimer having three
types of repeating modules (i.e. type I, II, and III repeats)
that mediate interactions with cells, ECM components
(including collagen [7]) and other FN molecules (for
review see [8]). The cognate FN–collagen-binding sites
are located at the 3/4–1/4 mammalian collagenase clea-
vage site on collagen [9,10] and within a region near the
N-terminus of FN that contains type I and II module
repeats [11–15].
FN polymerization is a cell-dependent process that
requires direct interactions with integrin receptors [16–
19]. Once engaged with integrins, FN undergoes a con-
formation change that exposes a cryptic site for FN–FN
polymerization [20,21]. Seminal studies showed antibody
binding to the collagen-binding site on FN-inhibited col-
lagen fibrillogenesis [22]. Interestingly, there was a reci-
procal dependence ofFNfibril assembly and collagenfibril
assembly; fibroblasts from theMov13mouse (in which the
COL1A1 gene is inactivated by retroviral insertion in an
intron) establish a sparse FN network, which can be
restored by transfection of the COL1A1 gene [23].
The requirement of FN for collagen fibril assembly is not
restricted to fibroblasts. Collagen fibril assembly by vas-
cular smooth muscle cells was inhibited by an anti-a2b1
integrin antibody and accelerated by an a2b1 integrin
antibody that stimulates a high-affinity binding state of
the integrin [24]. In the same study, newly assembled
collagen fibrils were found to colocalize with newly
assembled FN fibrils. Also, the inhibition of FN assembly
with an anti-a5b1 integrin antibody completely inhibited
collagen assembly. Of further interest, disruption of
smooth muscle cell actin microfilaments using cytocha-
lasin resulted in almost no collagen fibril assembly on the
cells [24].
It seems probable, therefore, that FN fibril assembly and
collagen fibril assembly have mechanistic elements inCurrent Opinion in Cell Biology 2008, 20:495–501common, involving functional integration of the cytoske-
leton with plasma membrane-located integrins. In the
case of FN, an a5b1 integrin-induced conformational
change is necessary to promote fibrillogenesis. It is less
clear how integrins and FN catalyze collagen fibrillogen-
esis. A tantalizing possibility is that FN and/or integrins
induce a conformational change in collagen to accelerate
fibrillogenesis. Alternatively, collagen molecules might
be brought into close proximity on the surface of FN
fibrils or by the engagement with integrins (e.g. a2b1).
The site of collagen–FN–integrin interactions during
collagen fibrillogenesis is unknown. Procollagen and
FN have been colocalized in the secretory pathway of
cultured fibroblasts [25], therefore it is possible that FN–
procollagen interactions are established before the mol-
ecules are secreted. Furthermore, procollagen can be
cleaved to collagen within the cell [26–28], which might
also mean that FN(monomer)–collagen(monomer) inter-
actions occur before secretion. Additional research is
needed to determine if FN–procollagen–collagen com-
plexes are copresented to integrins at the plasma mem-
brane or within the secretory pathway. Collagen fibril
assembly in embryonic development occurs in recesses of
the plasma membrane [29,30], and newly formed col-
lagen fibrils occur in plasma membrane protrusions called
fibripositors [26]. Further studies are needed to deter-
mine if plasma membrane recesses and fibripositors are
special sites of FN and collagen fibril assembly.
The nucleators — collagens V and XI
The Ehlers-Danlos syndrome (EDS) is characterized by
joint hypermobility and skin laxity and can be caused by
mutations in a variety of ECM genes including collagen V
and tenascin-X. In elegant studies of EDS,Wenstrup et al.
showed that collagen V is essential for the assembly of
collagen I-containing fibrils in vivo [31,32]. Collagen V
codistributes with collagen I [33] and mice lacking col-
lagen V die at embryonic day 10 because of cardiovascular
failure associated with a lack of collagen fibrils in the
mesenchyme. Heterozygous mice are viable and have a
50% reduction in fibril number and dermal collagen
content, caused either by a direct or indirect consequence
of half normal levels of collagen V protein. This result is
entirely consistent with a study of fibroblasts from an
EDS-affected individual with COL5A1 haploinsuffi-
ciency in which the total incorporation of collagen into
collagen fibrils was reduced by half and was associated
with a proportionate decrease in fibril number [32]. Col-
lagen V contains B clade polypeptide chains having
extended thrombospondin-like and variable domains at
the N-termini [34]. Electron microscope studies have
shown that the triple helical domain of collagen V is
buried in the fibril with the N-terminal domains at the
fibril surface. The prime location of collagen V at the fibril
core and its persistence in the final fibril indicates that thiswww.sciencedirect.com
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fibrils in vivo [35,36,37].
Collagen XI shares structural homology with collagen V
and appears to have a similar nucleating function.
Together with collagens II and IX, collagen XI forms
D-periodic heterotypic fibrils in cartilage [38–43]. Carti-
lage fibrils exist in distinct populations of ‘thin’ (16-nm
diameter) and ‘thick’ (40-nm diameter) fibrils and col-
lagen XI is found exclusively in the thin fibrils [39].
Electron microscopy studies show that thin cartilage
fibrils are constructed from 14 tilted 4-nm-diameter
microfibrils, in a 10 + 4 arrangement, with collagen XI
located in microfibrils at the core of the fibril [35]
(Figure 1).
These observations are relevant to the cho/cho
mouse and human osteochondrodysplasias caused by
mutations in the genes for collagen XI. Autosomal
recessive chondrodysplasia (cho) affects the cartilage
in limbs, ribs, mandibles, and trachea and is accom-
panied by the absence of thin fibrils [44]. The causative
mutation in the cho/cho mouse is localized in the gene
encoding the a1(XI) chain of collagen XI [45], resultingFigure 1
Schematic of the 10 + 4 microfibril structure of a thin cartilage collagen fibri
surrounded by 10 microfibrils at the surface. The collagen XI/IX/II assembly is
the fibril assembly mechanism. Blue: collagen II molecules; yellow: collagen X
like domains of collagen XI (yellow) are shown extending from the core mic
University of Washington, Seattle).
www.sciencedirect.comin alternative assemblies of collagen XI molecules in
the ECM [46]. The absence of thin cartilage fibrils in
the cho/cho mouse suggests that collagen XI is required
to nucleate the assembly of the thin fibrils. Like the
thin fibrils in cartilage, the thin heterotypic collagen I/V
fibrils in the corneal stroma also have a microfibrillar
substructure [47].
Regulators
Numerous proteins, glycoconjugates, and small mol-
ecules have been shown to influence the rate of assembly,
size, and structure of collagen fibrils formed in vitro. In
some instances mouse models have been generated for in
vivo analysis. The list is extensive and a comprehensive
review of these proteins is outside the scope of this article.
However, the molecules that have attracted most atten-
tion are the N-propeptides of collagen I (see [48] and
references therein), crosslinking enzymes such as lysyl
oxidase (see [49] and references therein), tenascin-X,
thrombospondin 2 [50,51], cartilage oligomeric matrix
protein (COMP) [52], matrilins [53], perlecan [54],
and the small leucine-rich proteoglycans decorin [55],
biglycan [56], fibromodulin [57,58], and lumican
[57,59,60].l. A pair of collagen XI microfibrils comprise half of a 4 microfibril core
a crosslinked heteropolymer, as is V/I, and is an important component of
I molecules; red: collagen IX molecules. The N-terminal thrombospondin-
rofibrils onto the fibril surface (model kindly provided by Dr David Eyre,
Current Opinion in Cell Biology 2008, 20:495–501
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of expression is associated with the number of collagen
fibrils, and its deficiency in humans is associated with
EDS. The gene for tenascin-X was the first EDS gene not
to encode a fibrillar collagen or procollagen processing
enzyme [61]. Subsequent analysis of a tenascin-X murine
model of EDS led to further surprising observations
[62]; mice lacking tenascin-X had collagen fibrils of
normal size and shape but the packing density of the
fibrils in the dermis was much reduced, leading to a 30%
reduction in collagen content in skin. Interestingly, skin
fibroblasts from the null animals had near normal collagen
synthesis but a significant deficit in the amount of col-
lagen deposited into insoluble matrix. This led to the
conclusion that tenascin-X deficiency does not interfere
with collagen synthesis or processing, but, rather, acts by
regulating fibril assembly.Figure 2
Hypothetical model of collagen fibril nucleation at the plasma membrane. (1)
integrin with the cytoskeleton (red lines) causes a conformational change in FN
FN. (3) Collagen I, procollagen I (black), and collagen V (purple) engage with
(interlocking dimers) shown bound to procollagen. (4) Activated collagen int
facilitates fibril formation. (5) Collagen fibril formation at the cell surface. (6) In
determine fibril diameter, organization, and spacing. Parts of the schematic
Current Opinion in Cell Biology 2008, 20:495–501The current evidence suggests that tenascin-X regulates
the spacing between fibrils by binding directly via its C-
terminal fibrinogen-like domain and via its 10th and 11th
FN type III repeats to decorin located on the surface of
collagen fibrils ([63–65] and reviewed by [66]). Tenascin-
X also accelerates collagen fibril formation in vitro [67]
and has an additive effect on the rate of collagen fibril
formation in the presence of collagen VI [68].
Perspectives
The importance of collagen V, FN, a5b1, and a2b1
integrins in collagen fibrillogenesis implicates that these
molecules are at a common membrane-located site for
collagen fibril assembly. Figure 2 shows a theoretical
scheme for collagen fibrillogenesis that incorporates what
is currently known about the interaction of these mol-
ecules. It is presented here purely to stimulate discussionDimeric FN (black) binds to a5b1 integrins (green). (2) Engagement of the
with subsequent fibril formation. Additional receptors (orange bars) bind
FN at the fibril surface to facilitate collagen fibril formation. Decorin
egrins (e.g. a2b1) bind collagen and induce a conformation change that
teractions between collagen fibrils (e.g. including tenascin-X and decorin)
are adapted from Mao and Schwarzbauer [8] and Bristow et al. [66].
www.sciencedirect.com
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mediated FN assembly is shown preceding collagen fibril
assembly. However, copolymerization might occur, the
order of assembly might be cell specific, and other (as yet
unidentified) proteins are likely to be involved. Dimeric
decorin is shown attached to the surfaces of collagen
fibrils but this is not intended to exclude other small
leucine-rich proteoglycans or to exclude a role for mono-
meric proteoglycans in collagen fibril assembly.
Further studies are needed to determine the high-resol-
ution structure of collagen fibrils in vivo particularly in the
context of understanding the molecular basis of tissue
organization. Such structural studies should preferably be
performed on hydrated fibrils (ideally in situ) to ensure
that native structures and molecular interactions are
maintained. Building on new knowledge of fibril struc-
ture, major advances should follow in understanding how
fibrils interact with cells.
The crucial importance of the cytoskeleton and secretory
pathway in collagen fibrillogenesis is exemplified in
developing tendon in which newly formed fibrils occur
in plasma membrane channels and fibripositors. How-
ever, progress in studying plasma membrane channels
and fibripositors has been hampered by the lack of
suitable cell culture systems; cells in monolayer do not
have channels nor do they assemble an ECM of organized
collagen fibrils. Recent studies show that three-dimen-
sional tensioned fibrin gels are a suitable cell culture
system for studying fibripositors and cell-mediated col-
lagen fibrillogenesis [69]. The use of three-dimensional
cell culture systems in combination with molecular per-
turbation methods and correlative light-and-electron
microscopy should lead to discoveries about the molecu-
lar mechanisms of FN–collagen–integrin-mediated ECM
assembly.
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